Research Output per year
Fingerprint Dive into the research topics where Hironari Hanaoka is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
Lupus Nephritis
Medicine & Life Sciences
Kidney
Medicine & Life Sciences
Systemic Lupus Erythematosus
Medicine & Life Sciences
Hydroxychloroquine
Medicine & Life Sciences
Mycophenolic Acid
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Alveolar Soft Part Sarcoma
Medicine & Life Sciences
Signal Recognition Particle
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1984 2019
A low perfusion-metabolic mismatch in 99mTl and 123I-BMIPP scintigraphy predicts poor prognosis in systemic sclerosis patients with asymptomatic cardiac involvement
Iida, H., Hanaoka, H., Okada, Y., Kiyokawa, T., Takakuwa, Y., Yamada, H., Okazaki, T., Ozaki, S., Yamaguchi, K., Nakajima, Y. & Kawahata, K., 2019 Jan 1, In : International Journal of Rheumatic Diseases.Research output: Contribution to journal › Article
Systemic Scleroderma
Radionuclide Imaging
Heart Failure
Perfusion
Magnetic Resonance Imaging
Glucocorticoid, immunosuppressant, hydroxychloroquine monotherapy, or no therapy for maintenance treatment in systemic lupus erythematosus without major organ manifestations
Hanaoka, H., Iida, H., Kiyokawa, T., Takakuwa, Y. & Kawahata, K., 2019 Jan 1, In : Clinical Rheumatology.Research output: Contribution to journal › Article
Hydroxychloroquine
Immunosuppressive Agents
Systemic Lupus Erythematosus
Glucocorticoids
Prednisolone
High plasma mycophenolate acid concentration in the early phase of induction therapy predicts good renal outcome in lupus nephritis
Kiyokawa, T., Hanaoka, H., Iida, H., Ishimori, K., Takakuwa, Y., Okazaki, T., Ozaki, S. & Kawahata, K., 2019 Jan 1, In : Modern Rheumatology.Research output: Contribution to journal › Article
Mycophenolic Acid
Lupus Nephritis
Kidney
Acids
Therapeutics
Hydroxychloroquine improves the disease activity and allows the reduction of the corticosteroid dose regardless of background treatment in Japanese patients with systemic lupus erythematosus
Hanaoka, H., Iida, H., Kiyokawa, T., Takakuwa, Y. & Kawahata, K., 2019 Jan 1, In : Internal Medicine. 58, 9, p. 1257-1262 6 p.Research output: Contribution to journal › Article
Open Access
Hydroxychloroquine
Systemic Lupus Erythematosus
Adrenal Cortex Hormones
Prednisolone
Therapeutics
1
Citation
(Scopus)
Low additive effect of hydroxychloroquine on Japanese patients with systemic lupus erythematosus taking calcineurin inhibitor
Hanaoka, H., Iida, H., Kiyokawa, T., Takakuwa, Y. & Kawahata, K., 2019 Mar 1, In : International Journal of Rheumatic Diseases. 22, 3, p. 468-472 5 p.Research output: Contribution to journal › Article
Hydroxychloroquine
Systemic Lupus Erythematosus
Prednisolone
Immunosuppressive Agents
Calcineurin Inhibitors